Search - tctmd.com

Displaying 121 - 140 of 223

Sort: Relevancy | Date

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

L.A. McKeown

February 24, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

Same Drop in MI, HF Admissions Seen in COVID-19’s Second Wave

Shelley Wood

January 22, 2021

News Daily News

Hospitalization for HF After Acute MI More Common in Women Than Men

L.A. McKeown

January 15, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Conference News AHA 2020

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

Todd Neale

November 17, 2020

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Shelley Wood

September 30, 2020

News Daily News

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

Shelley Wood

September 22, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2020

Shelley Wood

July 02, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2020

Shelley Wood

June 04, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2020

Shelley Wood

May 01, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

Advertisement

Roughly 80% of ESC Guideline Writers Have Financial COIs

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Same Drop in MI, HF Admissions Seen in COVID-19’s Second Wave

Hospitalization for HF After Acute MI More Common in Women Than Men

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

More Women Than Men Develop HF or Die After STEMI

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

TCTMD’s Top 10 Most Popular Stories for July 2020

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

TCTMD’s Top 10 Most Popular Stories for June 2020

TCTMD’s Top 10 Most Popular Stories for May 2020

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

TCTMD’s Top 10 Most Popular Stories for April 2020

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content